Study poses new questions about calcium-channel blockers.
Jeffers
E R
ER
D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D048909:Diabetes Complications; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D015737:Nisoldipine / Q000009:adverse effects / Q000627:therapeutic use
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D015737:Nisoldipine